Fields of the invention include palladium nanoparticles and electrochemical cells. Palladium nanoparticles of the invention are widely applicable in applications including, for example, biomedical applications, sensors, and energy storage, conversion and generation devices and systems.
Palladium nanoparticles have many recognized applications. Example applications include in high capacity hydrogen storage, high efficiency batteries, photosynthetic-energy conversion, catalysis for transformation and synthesis of novel chemical compounds with technological and biomedical applications. See, Horinouchi et al, “Hydrogen Storage Properties of Isocyanide-Stabilized Palladium Nanoparticles” Langmuir, 22 (4), pp 1880-84 (2006); Yu Lei et al, “Amine Synthesis of Porous Carbon Supported Palladium Nanoparticle Catalysts by Atomic Layer Deposition: Application for Rechargeable Lithium-O2Battery,” Nano Lett., 13 (9), pp 4182-89 (2013); Yi Zhang et al., “Palladium nanoparticles deposited on silanized halloysite nanotubes: synthesis, characterization and enhanced catalytic property,” Scientific Reports 3, Article number: 2948; B. P. Vinayan et al, “Solar light assisted green synthesis of palladium nanoparticle decorated nitrogen doped graphene for hydrogen storage application,” J. Mater. Chem. A, 1, 11192-11199 (2013).
Palladium nanomaterials also find applications as sensors, such as in artificial noses, often referred to as electronic noses, for sensing the presence of toxic gases, bio agents, and explosives. Changes in conductivity of palladium nanoparticles embedded in the sensors enable piezoelectric material changes in frequency that can be measured. Sensors embedded with palladium nanoparticles can also provide fluorescent optical fibers changes in color thus leading to molecular recognition of species, pre-processing of the neural signal and transduction of the signal. Electrochemical sensors, either conductance based or potentiometric (field effect transistor), derived from palladium nanoparticles find applications in the design and development of sophisticated diagnostic devices with applications in defense and biomedical sectors.
Despite widespread interest in and applications for engineered palladium nanoparticles, there remains a need for methods for the reproducible fabrication of well-defined and size tunable palladium nanoparticles. Present methods typically use toxic chemical precursors, and the ability to produce monodisperse palladium nanoparticles remains elusive.
Nanomedicine is an emerging area of medicine that utilizes nanoparticles for the detection and treatment of various diseases and disorders. Nanoparticles are tiny fragments of metals (or non metals) that are 100,000 times smaller than the width of human hair. Nanoparticles typically have different properties than naturally occurring bulk materials. Collateral properties emanate when materials, especially metals, are reduced to dimensions measured in nanometers. Nanoparticles exhibit properties that are unique from their corresponding naturally occurring bulk material.
Nanoparticles within the size range of about 1-50 nanometers have a size that can be correlated to cells, viruses, proteins and antibodies. The size resemblance that such nanoparticles have to living cells and cell components are of great interest to medical research because cells are primary components of all life (humans and animals).
The invention provides stabilized, biocompatible palladium nanoparticles that are stabilized with material from epigallocatechin Gallate (EGCG). The invention also provides electrochemical cells that include EGCG stabilized nanoparticles, and an electrolyte. In preferred embodiments, EGCG palladium nanoparticles are in D2O or H2O, and preferred electrolytes are adjusted for conductivity with LiOD and LiOH. The invention also provides for deposition of EGCG palladium nanoparticles. A method of electrolysis of the invention includes applying current to a cell including EGCG palladium nanoparticles. An energy conversion system applies current to a cell of the invention and collects heat energy. A net energy gain is measured in experimental energy conversion systems.
The invention provides stabilized, biocompatible palladium nanoparticles that are stabilized with material from polyphenols- or flavanoids-rich plant material, and specifically with EGCG (epigallocatechin-gallate). EGCG can be from a commercial source (e.g., Sigma Aldrich, St. Louis, Mo., USA), or can be derived from green tea. The palladium nanoparticles of the invention can be fabricated with an environmentally friendly method for making biocompatible stabilized palladium nanoparticles. Fabrication methods of the invention require only palladium salts as precursors. No other man-made chemicals are employed in the overall fabrication process, and there are accordingly no harsh chemicals utilized in the fabrication or harsh byproducts formed during the fabrication. Fabrication processes of the invention are therefore environmentally friendly and biologically benign.
Preferred embodiments provide an environmentally friendly green nanotechnology pathway for the production of palladium nanoparticles. Methods of the invention use EGCG as an electron reservoir and a reduction agent, to reduce palladium salt to corresponding palladium nanoparticles in the absence of any other reduction agent and without any harsh chemicals. A preferred process for forming palladium nanoparticles consists of reacting palladium salt with EGCG. No toxic chemical reduction agents are used, e.g. methods avoid any use of toxic agents such as hydrazine, sodium borohydride etc. A preferred embodiment consists simply of mixing green tea leaves with palladium salt in water. Another preferred embodiment consists of mixing tea leaves with palladium salt in heavy water.
Methods of the invention can produce well-defined and controlled particle size, charge and size distribution pattern. In preferred embodiments, a high basic pH is achieved through mixing with lithium hydroxide (LiOH) and lithium duteroxide (LiOD).
Palladium nanoparticles of the invention can be produced in a preferred size range from 45 nm to 70 nm. EGCG palladium nanoparticles would not settle down and hence could not be washed before imaging. Therefore, the size range was obtained by taking images and observing the particles in TEM as shown in the
The invention also provides an electrochemical cell. In the preferred embodiments, the cell includes a suspension of palladium nanoparticles. In other embodiments the nanoparticles are deposited upon a substrate in a liquid cell, which in preferred embodiments can be light water and in other embodiments is heavy water. Electrodes provide energy for electrolysis of the nanoparticles in solution. A thermal response is generated. The invention also provides an assembly and a method and apparatus for measurement of thermal response power (heat), when palladium nanoparticulate suspensions are electrolyzed in heavy and in light water. In preferred embodiments, the palladium nanoparticles are on a metallic substrate, a palladium substrate or a platinum substrate, and are preferably with deposited Single Wall Carbon Nano Tubes (SWCNT). Electrolyzing is conducted in preferred embodiments with Pulsed Current (PC)—Cathodic pulses followed by no current, Pulsed Reversed current (PRC)—that are cathodic pulses followed by anodic pulses, or Highly Modulated Current (HMC).
Preferred embodiments will now be discussed with respect to the drawings. The description includes descriptions of experiments. The drawings include schematic figures that are not to scale, which will be fully understood by skilled artisans with reference to the accompanying description. Features may be exaggerated for purposes of illustration. From the preferred embodiments and experiments, artisans will recognize additional features and broader aspects of the invention.
Example experiments synthesized palladium nanoparticles by reduction with EGCG in both light and heavy water. Measurements were used to characterize the formed particles. Experiments showed that EGCG also plays a unique role not only in the reduction of the metallic salt but also in stabilizing the reduced palladium atoms to form nanoparticles and maintain the monodisperse nature of the suspension to be electrolyzed onto a metallic substrate to generate heat. The B ring of EGCG is the most active and the abundant hydroxyl groups present in the aromatic structure of the polyphenols play a significant role in the reduction of sodium tetracholoropalladate to palladium atoms.
No further treatment is required prior to use of the stabilized, biocompatible palladium nanoparticles produced by the method in biomedical applications. The method produces stabilized, biocompatible palladium nanoparticles that are suitable for use within the body (in vivo) for diagnostic and treatment procedures. Stabilized, biocompatible palladium nanoparticles of the invention are suitable for direct administration into the human body through oral or intravenous routes. The methods produce palladium nanoparticles that require no further purification, that are biocompatible and stable. While the particles are stable as produced, an additional stabilizing agent such as gum Arabic can provide additional stability.
In the following experiments, EGCG was obtained from Sigma Aldrich, St. Louis, Mo., USA, which was mixed with light water or heavy water and palladium salts. Palladium nanoparticles produced by this process do not require any external chemical to stabilize the palladium nanoparticles. The methods provide a robust EGCG coating on palladium nanoparticles, which are stable against agglomerations.
EGCG Palladium Nanoparticle Production in H2O
1.6 mM solution of sodium tetra choloropalladate Sigma Aldrich (St. Louis, Mo., USA) salt solution was prepared and added to 0.8 mM EGCG Sigma Aldrich (St. Louis, Mo., USA) solution with distilled water as the base at room temperature. The solution was stirred for 24 hours and spectral data was collected every hour till 6 hours and at 24 hours.
EGCG Palladium Nanoparticles in D2O
1.6 mM solution of sodium tetra choloropalladate salt solution was prepared and added to 0.8 mM EGCG solution with heavy water as the base at room temperature. Care was taken so that the entire reaction took place with minimal light interaction and also was performed in a nitrogen environment to avoid oxygen interaction with the reaction mixture. The solution was stirred for 24 hours and spectral data was collected every hour till 6 hours and at 24 hours.
Measurements and Characterization
The spectroscopic measurements were performed using a Varian Cary 50 UV-Vis spectrophotometer and disposable cuvettes with a volume of 1 mL and a path length of 10 mm. The hydrodynamic diameter and zeta potential were obtained using Zetasizer Nano S90 (Malvern Instruments Ltd. USA). Transmission Electron Microscope (TEM) images were obtained on a JEOL 1400 TEM (JEOL, LTE, Tokyo, Japan). The conductivity readings were obtained using PC700 be, benchtop conductivity meter obtained from Oakton Instruments IL, USA.
Characterization of the EGCG Palladium Nanoparticles
The TEM images of
Electrochemical Cell, Energy Conversion, Electrolysis & Co-Deposition
An electrochemical cell was also constructed in an experiment. The cell is shown in
The experimental cell of
Power output: Pout=k*[T4−T5]
Electrolyte
EGCG palladium nanoparticles: Palladium nanoparticle (PdNP) suspension in (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (EGCG) was used as an electrolyte. Conductivity was adjusted by adding LiOH/LiOD;
Output Power Calculations
Output power; Pout has been measured using the temperature difference between inner aluminum cylindrical wall and outer aluminum cylindrical wall temperature, T4 and T5 respectively.
Power output: Pout=k*[T4−T5]
Where k is the overall heat coefficient
Input Power and Net Input Power Calculations
In thermodynamically open (although physically partially closed) cells such as the electrochemical cell presented in
P
In
=IV
P
Inet
I(V−VTN)
Where VTN, the thermo-neutral voltage, is 1.54V for the electrolysis of D2O and is 1.48V for H2O, and PInI and V are all functions of time. PInet; net input power.
EGCG Palladium Nanoparticles in D2O (EXP 1039)
EGCG in H2O (EXP 1040)
EGCG Palladium Nanoparticles D2O and LiOD (EXP 1042)
During first 140 hours of the experiment at net input power of 0.05 W, the cell showed little thermal response power of 0.064 W. When the net input power was increased to 3.8 W, the thermal response increased up to 0.29 W. However when the input power was dropped back to 0.05 W the thermal response dropped back to ˜0.044 W.
EGCG Palladium Nanoparticles D2O and LiOD (EXP 1056)
EGCG Palladium Nanoparticles in D2O (EXP 1080)
EGCG Palladium Nanoparticles in D2O (EXP 1085)
Pd Nanoparticle Deposition on Pd Foil
Electrochemistry provides for deposition of metallic nanoparticles and for electrode surface modification. Deposition of metallic nanoparticle with uniform size on the surface of conductive substrate requires strong metallic nanoparticle attachment.
An electrophoretic deposition (EPD) technique was used in the experiments to deposit Pd nanoparticles with good mechanical and chemical properties directly on a variety of substrates, such as Pd foil and Pd+SWCNTs from different PdNP suspensions as an electrolyte.
The particles were deposited by direct current (DC) EPD to take advantage of the charging method to obtain uniform Pd nanoparticles on the surface of substrate with minimum aggregation and to avoid losing important properties achieved at nano-level. Pulse current (PC), pulse reverse current (PRC) and Highly Modulated current also can be applied.
Electrodeposition Technique:
Electrophoretic deposition was carried out at ambient temperature with a 25 ml of solution containing different concentration of Pd nanoparticles (X) with various type of PdNP suspension, in a glass cell.
Electrochemical deposition of Pd nanoparticle was carried out in two electrode (
Substrate Preparation:
A Pd foil with 50 μm thickness with a purity of about 99.99% of Alfa Aesar and an area of about 4 cm2 was used as a cathode. To remove oil trace from its surface, the substrate was etched in concentrated nitric acid (HNO3) for about 10 minutes.
Electrolyte:
Palladium nanoparticle (PdNP) suspension in (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (EGCG). Conductivity adjustment has been done by adding LiOH/LiOD.
1×=PdNP concentration in the suspension
5×=PdNP concentration which is five times higher than 1×PdNP suspension
While specific embodiments of the present invention have been shown and described, it should be understood that other modifications, substitutions and alternatives are apparent to one of ordinary skill in the art. Such modifications, substitutions and alternatives can be made without departing from the spirit and scope of the invention, which should be determined from the appended claims.
Various features of the invention are set forth in the appended claims.
This application claims priority under 35 U.S.C. §119 from prior U.S. provisional application Ser. No. 62/190,328, which was filed Jul. 9, 2015.
Number | Date | Country | |
---|---|---|---|
62190328 | Jul 2015 | US |